Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastrointestinal diagnostics and therapeutics market are aciphex, afinitor, akynzeo, dificid and Prilosec.
The report details the trend, potential and market size of Gastrointestinal Therapeutics and Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gastrointestinal Therapeutics and Diagnosticsmarket, defines the market attractiveness level of Gastrointestinal Therapeutics and Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gastrointestinal Therapeutics and Diagnostics industry, describes the types of Gastrointestinal Therapeutics and Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gastrointestinal Therapeutics and Diagnostics market and the development prospects and opportunities of Gastrointestinal Therapeutics and Diagnostics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gastrointestinal Therapeutics and Diagnostics market in Chapter 13.
By Player:
Salix Pharmaceuticals
AstraZeneca
Takeda Pharmaceutical Company
Abbott Laboratories
Eisai Co, Ltd
Johnson & Johnson
By Type:
Diagnostics
Therapeutics
By End-User:
Gastroenteritis
GI Bleeding
Irritable Bowel Syndrome
Peptic Ulcer Disease (PUD)
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gastrointestinal Therapeutics and Diagnostics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gastrointestinal Therapeutics and Diagnostics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gastrointestinal Therapeutics and Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gastrointestinal Therapeutics and Diagnostics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gastrointestinal Therapeutics and Diagnostics Market Analysis and Outlook to 2022
-
7.1 Global Gastrointestinal Therapeutics and Diagnostics Consumption (2017-2022)
-
7.2 United States Gastrointestinal Therapeutics and Diagnostics Consumption (2017-2022)
-
7.3 Europe Gastrointestinal Therapeutics and Diagnostics Consumption (2017-2022)
-
7.4 China Gastrointestinal Therapeutics and Diagnostics Consumption (2017-2022)
-
7.5 Japan Gastrointestinal Therapeutics and Diagnostics Consumption (2017-2022)
-
7.6 India Gastrointestinal Therapeutics and Diagnostics Consumption (2017-2022)
-
7.7 South Korea Gastrointestinal Therapeutics and Diagnostics Consumption (2017-2022)
8 Region and Country-wise Gastrointestinal Therapeutics and Diagnostics Market Analysis and Outlook to 2028
-
8.1 Global Gastrointestinal Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.2 United States Gastrointestinal Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.3 Europe Gastrointestinal Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.4 China Gastrointestinal Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.5 Japan Gastrointestinal Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.6 India Gastrointestinal Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.7 South Korea Gastrointestinal Therapeutics and Diagnostics Consumption Forecast (2022-2028)
9 Global Gastrointestinal Therapeutics and Diagnostics Market Outlook by Types and Applications to 2022
-
9.1 Global Gastrointestinal Therapeutics and Diagnostics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Diagnostics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Therapeutics Consumption and Growth Rate (2017-2022)
-
9.2 Global Gastrointestinal Therapeutics and Diagnostics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Gastroenteritis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global GI Bleeding Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Irritable Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Peptic Ulcer Disease (PUD) Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Gastrointestinal Therapeutics and Diagnostics Market Outlook by Types and Applications to 2028
-
10.1 Global Gastrointestinal Therapeutics and Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gastrointestinal Therapeutics and Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Gastroenteritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global GI Bleeding Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Irritable Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Peptic Ulcer Disease (PUD) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Gastrointestinal Therapeutics and Diagnostics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gastrointestinal Therapeutics and Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gastrointestinal Therapeutics and Diagnostics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gastrointestinal Therapeutics and Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gastrointestinal Therapeutics and Diagnostics Market Competitive Analysis
-
14.1 Salix Pharmaceuticals
-
14.1.1 Salix Pharmaceuticals Company Details
-
14.1.2 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product and Service
-
14.2 AstraZeneca
-
14.2.1 AstraZeneca Company Details
-
14.2.2 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product and Service
-
14.3 Takeda Pharmaceutical Company
-
14.3.1 Takeda Pharmaceutical Company Company Details
-
14.3.2 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product and Service
-
14.4 Abbott Laboratories
-
14.4.1 Abbott Laboratories Company Details
-
14.4.2 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product and Service
-
14.5 Eisai Co, Ltd
-
14.5.1 Eisai Co, Ltd Company Details
-
14.5.2 Eisai Co, Ltd Gastrointestinal Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Eisai Co, Ltd Gastrointestinal Therapeutics and Diagnostics Product and Service
-
14.6 Johnson & Johnson
-
14.6.1 Johnson & Johnson Company Details
-
14.6.2 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gastrointestinal Therapeutics and Diagnostics
-
Figure Gastrointestinal Therapeutics and Diagnostics Picture
-
Table Global Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gastrointestinal Therapeutics and Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gastrointestinal Therapeutics and Diagnostics Consumption by Country (2017-2022)
-
Figure United States Gastrointestinal Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Europe Gastrointestinal Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure China Gastrointestinal Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Japan Gastrointestinal Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure India Gastrointestinal Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gastrointestinal Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Therapeutics and Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure United States Gastrointestinal Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gastrointestinal Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gastrointestinal Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gastrointestinal Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gastrointestinal Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gastrointestinal Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Gastroenteritis Consumption and Growth Rate (2017-2022)
-
Figure Global GI Bleeding Consumption and Growth Rate (2017-2022)
-
Figure Global Irritable Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Global Peptic Ulcer Disease (PUD) Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastroenteritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GI Bleeding Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Irritable Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peptic Ulcer Disease (PUD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gastrointestinal Therapeutics and Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gastrointestinal Therapeutics and Diagnostics Export by Region (Top 5 Countries) (2017-2028)
-
Table Salix Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Gastrointestinal Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product and Service
-
Table Takeda Pharmaceutical Company (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product and Service
-
Table Eisai Co, Ltd (Foundation Year, Company Profile and etc.)
-
Table Eisai Co, Ltd Gastrointestinal Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Co, Ltd Gastrointestinal Therapeutics and Diagnostics Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product and Service
-
